Marius Hoeper, MD, offers expert perspectives on the recently FDA-approved sotatercept, focusing on its mechanism of action, potential cost implications, and potential advantages and disadvantages it ...

Referral to a PH expert centre, including for right heart catheterisation, confirms the diagnosis. Supportive measures include diuretic therapy for symptoms of right heart failure and fluid retention, ...

Future Cardiol. 2013;9(3):335-349. The pivotal trial that established sildenafil as a treatment for WHO Group 1 PH was the SUPER trial. [102] SUPER enrolled WHO functional class II and III PAH ...

A new study has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH). A new study from researchers with UCLA Health and ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

Pulmonary hypertension remains one of the most challenging and underdiagnosed conditions in respiratory medicine. However, with a well-structured approach and dedicated efforts, significant ...

Dr. Sathish Kumar Krishnan has spent years tackling a silent crisis in healthcare: pulmonary hypertension (PH), a condition that affects thousands but remains underdiagnosed and under-treated. As a ...

Some illnesses are difficult to recognize and can take months to diagnose. That's the case with pulmonary hypertension. Left untreated, the disease is life-threatening. Fifteen years ago, there were ...

Q: I am an 85-year-old woman, and I’ve been incredibly healthy all my life, until a couple of years ago. Recently, my complaints of breathlessness and fatigue took me to a pulmonologist, who diagnosed ...